Cargando…

517 Specific IgE to Recombinant Allergens of Latex and Foods in Patients With Spina Bifida

BACKGROUND: To identify the profile of specific IgE to recombinant allergens of Hevea brasiliensis and fruits in patients with spina bifida and latex allergy. METHODS: Cross-sectional study with 210 pacients aged 0 to 18 who have spina bifida and who have been followed in a Reference Hospital in Sao...

Descripción completa

Detalles Bibliográficos
Autores principales: Garro, Laila Sabino, Motta, Antonio Abilio, Kalil, Jorge, Giavina-Bianchi, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization Journal 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512785/
http://dx.doi.org/10.1097/01.WOX.0000411632.09420.47
_version_ 1782251801361252352
author Garro, Laila Sabino
Motta, Antonio Abilio
Kalil, Jorge
Giavina-Bianchi, Pedro
author_facet Garro, Laila Sabino
Motta, Antonio Abilio
Kalil, Jorge
Giavina-Bianchi, Pedro
author_sort Garro, Laila Sabino
collection PubMed
description BACKGROUND: To identify the profile of specific IgE to recombinant allergens of Hevea brasiliensis and fruits in patients with spina bifida and latex allergy. METHODS: Cross-sectional study with 210 pacients aged 0 to 18 who have spina bifida and who have been followed in a Reference Hospital in Sao Paulo, Brazil. Patients were submitted to a questionnaire about immediate latex allergy symptoms. Their blood were collected for the detection of serum specific IgE to latex, specific IgE to rHev b1, 3, 5, 6.01, 6.02, 8, 9, 11, and specific IgE to avocado, banana, chestnut, potato and papaya, through ImmunoCAP technique. RESULTS: Patients' mean age was 7.9 years, and 108 (51%) were female. The mean time to the first surgery was 40 days, and patients presented an average of 4 or more surgeries during their lives. Forty-seven (22%) patients reported symptoms related to latex, predominantly cutaneous symptoms (85%). The latex recombinant allergens most related with symptoms were rHev b1 (19 patients, 68%) and rHev b3 (11 patients, 39%). On the other hand, tests were also positive to rHev b5 (9 patients, 32%), rHev b6.01 (12 patients, 43%), rHev b6.02 (12 patients, 43%), rHev b9 (patients 1, 4 %), and rHev b11 (9 patients, 32%). All tests were negative to rHev b8. Although, 36 (17%) patients tested positive to at least one of the food allergens, they did not present symptoms related to them. Balloons and latex gloves were the main objects associated with the onset of symptoms. CONCLUSIONS: In this study, the prevalence of latex allergy was 22%. We observed a different profile of latex sensitization in relation to the literature. Patients do not present latex-fruit syndrome, in spite of cross-sensitization.
format Online
Article
Text
id pubmed-3512785
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher World Allergy Organization Journal
record_format MEDLINE/PubMed
spelling pubmed-35127852012-12-21 517 Specific IgE to Recombinant Allergens of Latex and Foods in Patients With Spina Bifida Garro, Laila Sabino Motta, Antonio Abilio Kalil, Jorge Giavina-Bianchi, Pedro World Allergy Organ J Abstracts of the XXII World Allergy Congress BACKGROUND: To identify the profile of specific IgE to recombinant allergens of Hevea brasiliensis and fruits in patients with spina bifida and latex allergy. METHODS: Cross-sectional study with 210 pacients aged 0 to 18 who have spina bifida and who have been followed in a Reference Hospital in Sao Paulo, Brazil. Patients were submitted to a questionnaire about immediate latex allergy symptoms. Their blood were collected for the detection of serum specific IgE to latex, specific IgE to rHev b1, 3, 5, 6.01, 6.02, 8, 9, 11, and specific IgE to avocado, banana, chestnut, potato and papaya, through ImmunoCAP technique. RESULTS: Patients' mean age was 7.9 years, and 108 (51%) were female. The mean time to the first surgery was 40 days, and patients presented an average of 4 or more surgeries during their lives. Forty-seven (22%) patients reported symptoms related to latex, predominantly cutaneous symptoms (85%). The latex recombinant allergens most related with symptoms were rHev b1 (19 patients, 68%) and rHev b3 (11 patients, 39%). On the other hand, tests were also positive to rHev b5 (9 patients, 32%), rHev b6.01 (12 patients, 43%), rHev b6.02 (12 patients, 43%), rHev b9 (patients 1, 4 %), and rHev b11 (9 patients, 32%). All tests were negative to rHev b8. Although, 36 (17%) patients tested positive to at least one of the food allergens, they did not present symptoms related to them. Balloons and latex gloves were the main objects associated with the onset of symptoms. CONCLUSIONS: In this study, the prevalence of latex allergy was 22%. We observed a different profile of latex sensitization in relation to the literature. Patients do not present latex-fruit syndrome, in spite of cross-sensitization. World Allergy Organization Journal 2012-02-17 /pmc/articles/PMC3512785/ http://dx.doi.org/10.1097/01.WOX.0000411632.09420.47 Text en Copyright © 2012 by World Allergy Organization
spellingShingle Abstracts of the XXII World Allergy Congress
Garro, Laila Sabino
Motta, Antonio Abilio
Kalil, Jorge
Giavina-Bianchi, Pedro
517 Specific IgE to Recombinant Allergens of Latex and Foods in Patients With Spina Bifida
title 517 Specific IgE to Recombinant Allergens of Latex and Foods in Patients With Spina Bifida
title_full 517 Specific IgE to Recombinant Allergens of Latex and Foods in Patients With Spina Bifida
title_fullStr 517 Specific IgE to Recombinant Allergens of Latex and Foods in Patients With Spina Bifida
title_full_unstemmed 517 Specific IgE to Recombinant Allergens of Latex and Foods in Patients With Spina Bifida
title_short 517 Specific IgE to Recombinant Allergens of Latex and Foods in Patients With Spina Bifida
title_sort 517 specific ige to recombinant allergens of latex and foods in patients with spina bifida
topic Abstracts of the XXII World Allergy Congress
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512785/
http://dx.doi.org/10.1097/01.WOX.0000411632.09420.47
work_keys_str_mv AT garrolailasabino 517specificigetorecombinantallergensoflatexandfoodsinpatientswithspinabifida
AT mottaantonioabilio 517specificigetorecombinantallergensoflatexandfoodsinpatientswithspinabifida
AT kaliljorge 517specificigetorecombinantallergensoflatexandfoodsinpatientswithspinabifida
AT giavinabianchipedro 517specificigetorecombinantallergensoflatexandfoodsinpatientswithspinabifida